Balyasny Asset Management LLC Cytek Biosciences, Inc. Transaction History

Balyasny Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$5.3 - $6.91 $156,503 - $204,045	-29,529 Reduced 64.52%	16,238 $90,000
Q1 2024 May 13, 2024	BUY	$6.29 - $9.15 $105,923 - $154,086	16,840 Added 58.22%	45,767 $307,000
Q4 2023 Feb 14, 2024	BUY	$4.1 - $9.51 $62,594 - $145,189	15,267 Added 111.76%	28,927 $263,000
Q3 2023 Nov 14, 2023	SELL	$5.52 - $9.5 $377,038 - $648,888	-68,304 Reduced 83.33%	13,660 $75,000
Q2 2023 Aug 14, 2023	SELL	$6.69 - $11.99 $267,967 - $480,259	-40,055 Reduced 32.83%	81,964 $699,000
Q1 2023 May 15, 2023	SELL	$8.44 - $13.47 $8,389 - $13,389	-994 Reduced 0.81%	122,019 $1.12 Million
Q4 2022 Feb 14, 2023	BUY	$9.71 - $15.86 $1.19 Million - $1.95 Million	123,013 New	123,013 $1.26 Million

134

71.7M

400

Ticker CTKB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 134,627,008
Market Cap $874M
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.